HomeRX • CVE
add
Biosyent Inc
Previous close
$11.25
Day range
$11.29 - $11.29
Year range
$8.24 - $12.13
Market cap
129.71M CAD
Avg Volume
2.89K
P/E ratio
18.34
Dividend yield
1.77%
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 8.80M | 6.32% |
Operating expense | 5.15M | -0.49% |
Net income | 1.61M | 11.19% |
Net profit margin | 18.34 | 4.56% |
Earnings per share | — | — |
EBITDA | 2.36M | 46.64% |
Effective tax rate | 28.33% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.94M | -39.13% |
Total assets | 41.36M | -0.41% |
Total liabilities | 6.36M | -6.10% |
Total equity | 35.00M | — |
Shares outstanding | 11.50M | — |
Price to book | 3.70 | — |
Return on assets | 11.54% | — |
Return on capital | 13.46% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.61M | 11.19% |
Cash from operations | 2.62M | 287.80% |
Cash from investing | 882.82K | 196.33% |
Cash from financing | -4.20M | -226.21% |
Net change in cash | -668.07K | 60.26% |
Free cash flow | 841.30K | 122.05% |
About
Founded
1947
Headquarters
Website
